Scientists made first synchronized heart tissue, enabling heart disease research and better drug tests

Briefing

February 24, 2017

Briefing	Heart Tissue – Scientists from York University have created first 3D heart tissue with three different types of rat cells that beat as one Application – Can lead to better and earlier drug testing, potentially avoiding harmful or toxic medications, as well as help labs study heart disease and transplant problems Product Commercialization – Created spinoff company OrganoLinX to commercialize substance used to stick cells together and provide custom 3D tissues on demand
Accelerator	Biotechnology and Bioinformatics
Sector	Healthcare/Health Sciences
Source	"Scientists create first 3-D synchronized-beating heart tissue," KurzweilAI, http://www.kurzweilai.net/; Rogozhnikov, D., et. al., "Scaffold free bio-orthogonal assembly of 3-dimensional cardiac tissue via cell surface engineering", Nature, http://www.nature.com/; "Matters of the heart: York U researchers create 3D beating heart," York Media Relations, http://news.yorku.ca/; AcceleratingBiz analysis
Original Publication Date	February 8, 2017

Related Briefings

Bioinformatics startups Benevolent AI and Insilico Medicine using artificial intelligence to discover and accelerate treatments for corona virus

February 12, 2020

GE Healthcare launched Edison Developer Program, platform for health providers to integrate artificial intelligence (AI) into smart devices and applications

November 27, 2019

European researchers invented artificial intelligence algorithm that can more efficiently predict quantum states of molecules, aiding design of new medicines or materials

November 20, 2019

Scientists at Queen Mary University of London explored potential of bacteria Escherichia coli to create bio Internet-of-Things (IoT) nanotechnologies, such as environmental sensors and therapies

November 4, 2019

Broad Institute researchers developed improved CRISPR gene editing system called prime editing that can correct 89% of genetic mutations

October 29, 2019

Go to page

Related Proof Points

Expected Company Adoption of Technologies by 2022

March 18, 2019

Percentage of U.S. Business and Government Decision-Makers Agreeing that Emerging Technologies Will Impact Industries by 2022

August 17, 2018

U.S. Bioscience-Related Venture Capital Investments

September 7, 2017

U.S. Bioscience-Related Patents Granted by Category

September 6, 2017

Annual U.S. Life Sciences IPO

September 2, 2017

Go to page

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Leave a comment